< Back to previous page


Means and methods for anti-vegf therapy

The present application relates to the field of cancer, particularly to colorectal cancer (CRC). A panel of biomarkers is presented hereinthat can be used to cluster CRC samples into distinct genetic subtypes. It further relates to the use of the clustering method on patients treated with an anti-VEGF therapy and the identification of anti-VEGF responsive genetic subtypes.
Patent Publication Number: EP3445869
Source: EPO
Year filing: 2017
Year approval: 2020
Year publication: 2019
Status: Requested
Technology domains: Biotechnology
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven